| Target Price | $281.01 |
| Price | $220.22 |
| Potential |
27.60%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Cardinal Health 2027 .
The average Cardinal Health target price is $281.01.
This is
27.60%
register free of charge
$306.60
39.22%
register free of charge
$219.40
0.37%
register free of charge
|
|
| A rating was issued by 24 analysts: 21 Analysts recommend Cardinal Health to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cardinal Health stock has an average upside potential 2027 of
27.60%
register free of charge
|
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 254.25 | 268.36 |
| 14.23% | 5.55% | |
| EBITDA Margin | 1.43% | 1.71% |
| 14.44% | 19.38% | |
| Net Margin | 0.67% | 1.10% |
| 3.88% | 63.17% |
20 Analysts have issued a sales forecast Cardinal Health 2027 . The average Cardinal Health sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Cardinal Health EBITDA forecast 2027. The average Cardinal Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
21 Cardinal Health Analysts have issued a net profit forecast 2027. The average Cardinal Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.23 | 12.68 |
| 12.09% | 75.38% | |
| P/E | 17.37 | |
| EV/Sales | 0.21 |
21 Analysts have issued a Cardinal Health forecast for earnings per share. The average Cardinal Health EPS is
This results in the following potential growth metrics and future valuations:
Cardinal Health...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 19 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Baird |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 19 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Baird:
Locked
➜
Locked
|
Aug 12 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


